PALOMA3 supports palbociclib use in advanced breast cancer

[News]

Advanced breast cancer patients who have failed prior endocrine treatment may receive a progression-free survival benefit if palbociclib is added to fulvestrant, a phase III trial indicates.

More... (http://www.news-medical.net/news/20150605/PALOMA3-supports-palbociclib-use-in-advanced-breast-cancer.aspx)